Causative Pathogens and Therapeutic Assessment of Cefprozil in Acute Otitis Media.
- Author:
Jin Han KANG
1
;
Jong Hyun KIM
;
Yong Soo PARK
;
Young Chul CHOI
;
Heil NOH
;
Hoon Shik YANG
;
Kyu Sung KIM
;
Yeon Sook MOON
;
Young Jin HONG
Author Information
1. Department of Pediatrics, College of Medicine, The Catholic University of Korea, Korea. kjhan@olmh.cuk.ac.kr
- Publication Type:In Vitro ; Original Article
- Keywords:
Acute otitis media(AOM);
Causative pathogens;
Cefprozil
- MeSH:
Bacteria;
Bacteriology;
Cefaclor;
Cefixime;
Child;
Diffusion;
Earache;
Fever;
Humans;
Otitis Media*;
Otitis*;
Pneumonia;
Prospective Studies
- From:Journal of the Korean Pediatric Society
2003;46(5):459-466
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: AOM is the most common bacterial URI in children. The bacteriology and antibiotic Tx of AOM in children has been studied in many countries. But, there is few study of causative pathogens and antibiotic Tx of AOM in our country. In this aspect, we performed prospective clinical study to confirm the causative pathogens and assess the clinical responses of cefprozil in AOM patients. METHODS: Thirty three AOM patients enrolled in this study. Tympanocentesis for isolation of causa tive pathogens were performed before Tx of cefprozil. The study patients received cefprozil with dose of 15 mg/kg/bid.po/day for 10-12 days, and initially assessed the clinical response at 4-5 days after receiving cefprozil and finally at the end visit. In vitro susceptibility tests of cefprozil to isolated pathogens were done by disc diffusion method, and in vitro susceptibility tests of cefaclor and cefixime to isolated pathogens were simultaneously performed. RESULTS: Bacterial pathogens[S. pneumoniae(10), H. influenzae(5), S. aureus(2), M. catarrhalis(1) and Group A stretococcus(1)] were isolated from 19 patients. Clinically, all patients had history of abrupt high fever except one. Tympanic perforation was dominant in pathogens isolated cases, and otalgia was significantly developed in non-pathogens isolated cases. The ages of pathogens isolated cases were usually below 2 years. Eighty four point nine percent of the patients including two cases with isolation of intermediate resistant S. pneumoniae were clinically improved. Antimicrobial in vitro activity to S. pneumoniae of cefprozil were superior than that of cefacor and cefixime. CONCLUSION: We confirm that bacteria has the causative role in about 60% cases, and S. pneumoniae is the most common pathogen. Clinically, there were some differences in symptoms, signs and ages between pathogens isolated and non-pathogens isolated cases. The clinical responses of cefprozil in our patients revealed similar outcomes to other countries. And we reconfirm that cefprozil may be clinically effective in cases of AOM due to intermediate resistant S. pneumoniae.
